PRESS RELEASE published on 06/16/2025 at 15:15, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.46% stake in Direct Line Insurance Group plc. Dealings made on 13 June 2025 Vanguard Group Dealings Stake Direct Line Insurance June 2025
BRIEF published on 06/05/2025 at 15:42, 1 year 3 months ago La participation du groupe Vanguard dans Direct Line Insurance Group révélée Actionnariat Titres Groupe Vanguard Code De Prise De Contrôle Ligne Directe
BRIEF published on 06/05/2025 at 15:42, 1 year 3 months ago Vanguard Group's Stake in Direct Line Insurance Group Revealed Securities Takeover Code Vanguard Group Shareholding Direct Line
PRESS RELEASE published on 06/05/2025 at 15:37, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.46% ownership in Direct Line Insurance Group plc as of 04 June 2025 Vanguard Group Ownership Disclosure Financial Interest Direct Line Insurance Stock Holdings
BRIEF published on 06/04/2025 at 15:42, 1 year 3 months ago Le groupe Vanguard révèle une participation substantielle dans Direct Line Insurance Groupe Vanguard Actions Ordinaires Code De Prise De Contrôle Divulgation Des Parties Prenantes Assurance Direct Line
BRIEF published on 06/04/2025 at 15:42, 1 year 3 months ago The Vanguard Group Discloses Substantial Stake in Direct Line Insurance Ordinary Shares Takeover Code Vanguard Group Direct Line Insurance Stakeholder Disclosure
PRESS RELEASE published on 06/04/2025 at 15:37, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.45% interest in Direct Line Insurance Group plc. Purchase of 11,824 ordinary securities at 3.02 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Direct Line Insurance Group
BRIEF published on 06/02/2025 at 15:57, 1 year 3 months ago The Vanguard Group Discloses Significant Stake in Direct Line Insurance Takeover Code Stake Disclosure Share Transactions Vanguard Direct Line Insurance
BRIEF published on 06/02/2025 at 15:57, 1 year 3 months ago Le groupe Vanguard révèle une participation significative dans Direct Line Insurance Transactions D'actions Code De Prise De Contrôle Avant-garde Divulgation Des Enjeux Assurance Direct Line
PRESS RELEASE published on 06/02/2025 at 15:52, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.45% stake in Direct Line Insurance Group plc as per Form 8.3 filing. Additional disclosure on Aviva plc also made Form 8.3 Vanguard Group Inc. Stake Disclosure Direct Line Insurance Group Plc Aviva Plc
Published on 09/11/2026 at 04:00, 5 hours 32 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 7 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 12 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 32 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 12 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 26 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 32 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 2 minutes ago Availability of the 2026 Interim Financial Report
